Elite Pharmaceuticals, Inc. (ELTP) Shareholders’ equity 2017–2026
Elite Pharmaceuticals, Inc. (ELTP) shareholders’ equity at each fiscal year-end, per SEC filings.
$98.9MFY2026 · since FY2017: $25.7M → $98.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $98.9M | +84.8% |
| FY2025 | $53.5M | -7.1% |
| FY2024 | $57.6M | +98.8% |
| FY2023 | $29.0M | +14.8% |
| FY2022 | $25.2M | +56.2% |
| FY2021 | $16.2M | +51.6% |
| FY2020 | $10.7M | +524.9% |
| FY2019 | -$2.5M | -154.9% |
| FY2018 | $4.6M | -82.2% |
| FY2017 | $25.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice